Skip to main content

Animations

MJFF Publications

1451 - 1460 of 6082 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Best OA location URL:
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.008
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The effect of limb selection methods on gait analysis in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysis
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-022-02547-9
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Targeting the inflammasome in Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.957705
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Interfacility Transfers for Seizure-Related Emergencies in the United States
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201319
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.2c14220
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00395-8
    Citation Count: 20
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.